Loratadin og dets aktive metabolit udskilles i modermælken hos ammende kvinder.
Preclinical data for loratadine reveal no special hazard for humans based on conventional studies of safety, pharmacology, repeated dose toxicity, genotoxicity and carcinogenicity.